… patients who underwent primary isolated coronary artery bypass grafting between 2013 and
2017 were identified from a contemporary … for patients with extensive coronary artery disease…

… clopidogrel has remained the cornerstone of treatment for patients with stable coronary artery
disease … stent thrombosis (especially after treatment with contemporary DES), and in those …

… as to whether their broad use in coronary artery disease (CAD) and heart failure is appropriate.
… the use of β-blockers in the contemporary management of patients with CAD and heart …

… The aim of the present study was to evaluate contemporary clinical characteristics and
outcomes of unstable angina patients after percutaneous coronary intervention (PCI) in …

… The use of clopidogrel for primary prevention of CVD in asymptomatic … order to hopefully
increase the representativeness of women in modern clinical trials. Importantly, female sex has …

… Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with
peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes …

… Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery
disease and chronic obstructive pulmonary disease. Thromb Haemost. 2017;117:1208–1216. …

… a problem of men, coronary artery disease (CAD) is the … mother underwent emergency
coronary artery bypass surgery … -platelet therapy with aspirin and clopidogrel from that time had a …

… , carotid stenosis of ≥50% or cerebral revascularization; diabetes; peripheral arterial disease;
… Use of clopidogrel in patients with contraindication to ticagrelor (eg history of intracranial …

… used in the context of coronary artery disease, acute coronary syndromes, and percutaneous
coronary … randomized 573 PCI patients receiving VKAs to TT vs VKA and clopidogrel, 69% …